Upgrade to SI Premium - Free Trial

Jazz Pharmaceuticals (JAZZ) PT Raised to $208 at BMO Capital

May 8, 2019 7:48 AM
BMO Capital analyst Gary Nachman raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles